Last reviewed · How we verify
Use of Intraoperative Intravenous Fentanyl — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Use of Intraoperative Intravenous Fentanyl (Use of Intraoperative Intravenous Fentanyl) — University of Sao Paulo General Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Use of Intraoperative Intravenous Fentanyl TARGET | Use of Intraoperative Intravenous Fentanyl | University of Sao Paulo General Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Use of Intraoperative Intravenous Fentanyl CI watch — RSS
- Use of Intraoperative Intravenous Fentanyl CI watch — Atom
- Use of Intraoperative Intravenous Fentanyl CI watch — JSON
- Use of Intraoperative Intravenous Fentanyl alone — RSS
Cite this brief
Drug Landscape (2026). Use of Intraoperative Intravenous Fentanyl — Competitive Intelligence Brief. https://druglandscape.com/ci/use-of-intraoperative-intravenous-fentanyl. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab